Evolving Frontline Treatment in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Coutre, Steven E. [1 ]
机构：
[1] Stanford Univ, Med Ctr, Med Hematol, Stanford, CA 94305 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2016年 / 14卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [41] A phase II study of the combination of lenalidomide and rituximab as frontline treatment in patients with chronic lymphocytic leukemia
    Strati, Paolo
    Thompson, Philip
    Keating, Michael
    Hinojosa, Christina
    Rodriguez, Diana
    Jain, Nitin
    Burger, Jan A.
    Estrov, Zeev
    O'Brien, Susan
    Wierda, William
    Ferrajoli, Alessandra
    LEUKEMIA & LYMPHOMA, 2017, 58 : 70 - 72
  • [42] The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)
    Wolfe, Heather R.
    Rein, Lindsay A. M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 448 - 454
  • [43] The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)
    Heather R. Wolfe
    Lindsay A. M. Rein
    Current Hematologic Malignancy Reports, 2021, 16 : 448 - 454
  • [44] Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy
    Sara Small
    Shuo Ma
    Current Hematologic Malignancy Reports, 2021, 16 : 325 - 335
  • [45] Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy
    Small, Sara
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (04) : 325 - 335
  • [46] The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
    Lampson, Benjamin L.
    Brown, Jennifer R.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (04) : 807 - 826
  • [47] Novel combination approaches with targeted agents in frontline chronic lymphocytic leukemia
    Lipsky, Andrew H.
    Lamanna, Nicole
    CANCER, 2023, 129 (01) : 18 - 31
  • [48] Indirect treatment comparison analysis of venetoclax plus obinutuzumab with standard frontline regimens for chronic lymphocytic leukemia
    Davids, Matthew
    Huntington, Scott
    Moreno, Carol
    Follows, George
    Cuneo, Antonio
    Humphrey, Kathryn
    Schary, William
    Sail, Kavita
    Song, Yanna
    Gao, Zhenguo
    Tang, Zhongwen
    Foa, Robin
    Hillmen, Peter
    LEUKEMIA & LYMPHOMA, 2020, 61 : 188 - 189
  • [49] Frontline treatment of chronic lymphocytic leukemia with obinutuzumab and chlorambucil: how does it work in "real-life"?
    Goede, Valentin
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (7-8): : 414 - 415
  • [50] The Evolving Role of Stem Cell Transplantation in Chronic Lymphocytic Leukemia
    Dreger, Peter
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (02) : 355 - +
12345